Genetic alterations of the TGF-β signaling pathway in colorectal cancer cell lines: A novel mutation in Smad3 associated with the inactivation of TGF-β-induced transcriptional activation

Prunier, 1999, Evidence that Smad2 is a tumor suppressor implicated in the control of cellular invasion, J. Biol. Chem., 274, 22919, 10.1074/jbc.274.33.22919 Xu, 2000, Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin–proteasome pathway, Proc. Natl. Acad. Sci. USA, 97, 4820, 10.1073/pnas.97.9.4820 Ikezoe, 1998, Analysis of the Smad3 gene in hematological malignancies, Int. J. Hematol., 68, 457, 10.1016/S0925-5710(98)00090-5 Park, 1994, Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta, Proc. Natl. Acad. Sci. USA, 91, 8772, 10.1073/pnas.91.19.8772 Fink, 2001, Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line, Cancer Res., 61, 256 Ku, 1999, Mutations in hMSH6 alone are not sufficient to cause the microsatellite instability in colorectal cancer cell lines, Eur. J. Cancer, 35, 1724, 10.1016/S0959-8049(99)00206-3 Oh, 1999, Establishment and characterization of 12 human colorectal-carcinoma cell lines, Int. J. Cancer, 81, 902, 10.1002/(SICI)1097-0215(19990611)81:6<902::AID-IJC11>3.0.CO;2-T Chen, 1998, Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer, Cancer Res., 58, 4805 Takagi, 1998, Somatic alterations of the SMAD-2 gene in human colorectal cancers, Br. J. Cancer, 78, 1152, 10.1038/bjc.1998.645 Arai, 1998, Genomic structure of the human Smad3 gene and its infrequent alterations in colorectal cancers, Cancer Lett., 122, 157, 10.1016/S0304-3835(97)00384-4 Hahn, 1998, Mutations of the DPC4/Smad4 gene in biliary tract carcinoma, Cancer Res., 58, 1124 Takakura, 1999, Allelic imbalance in chromosome band 18q21 and SMAD4 mutations in ovarian cancers, Genes Chromosomes Cancer, 24, 264, 10.1002/(SICI)1098-2264(199903)24:3<264::AID-GCC12>3.0.CO;2-Y Terdiman, 2002, High resolution analysis of chromosome 18 alterations in ulcerative colitis-related colorectal cancer, Cancer Genet. Cytogenet., 136, 129, 10.1016/S0165-4608(02)00522-8 Hung, 1995, Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma, JAMA, 273, 1908, 10.1001/jama.273.7.558 Zawel, 1998, Human Smad3 and Smad4 are sequence-specific transcription activators, Mol. Cell, 1, 611, 10.1016/S1097-2765(00)80061-1 Wrana, 1992, TGF beta signals through a heteromeric protein kinase receptor complex, Cell, 71, 1003, 10.1016/0092-8674(92)90395-S Massague, 2000, Transcriptional control by the TGF-beta/Smad signaling system, EMBO J., 19, 1745, 10.1093/emboj/19.8.1745 Xiao, 2001, Nucleocytoplasmic shuttling of Smad1 conferred by its nuclear localization and nuclear export signals, J. Biol. Chem., 276, 39404, 10.1074/jbc.M103117200 Xiao, 2003, A novel nuclear export signal in Smad1 is essential for its signaling activity, J. Biol. Chem., 278, 34245, 10.1074/jbc.M301596200 Pinto, 2003, Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas, J. Pathol., 200, 32, 10.1002/path.1327 Vellucci, 1997, Cloning and genomic organization of the human transforming growth factor-beta type I receptor gene, Genomics, 46, 278, 10.1006/geno.1997.5023 Wang, 2000, Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer, Cancer Res., 60, 4507 Chen, 2001, Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastases, Int. J. Cancer, 93, 653, 10.1002/ijc.1381 Massague, 1996, TGFbeta signaling: receptors, transducers, and Mad proteins, Cell, 85, 947, 10.1016/S0092-8674(00)81296-9 Uchida, 1996, Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers, Cancer Res., 56, 5583 Riggins, 1997, Frequency of Smad gene mutations in human cancers, Cancer Res., 57, 2578 Xiao, 2000, A distinct nuclear localization signal in the N-terminus of Smad3 determines its ligand-induced nuclear translocation, Proc. Natl. Acad. Sci. USA, 97, 7853, 10.1073/pnas.97.14.7853 Xiao, 2000, Importin beta mediates nuclear translocation of Smad3, J. Biol. Chem., 275, 23425, 10.1074/jbc.C000345200 Xu, 2003, Distinct domain utilization by Smad3 and Smad4 for nucleoporin interaction and nuclear import, J. Biol. Chem., 278, 42569, 10.1074/jbc.M307601200 Inman, 2002, Nucleocytoplasmic shuttling of Smads 2,3, and 4 permits sensing of TGF-beta receptor activity, Mol. Cell, 10, 283, 10.1016/S1097-2765(02)00585-3